1035 / 1498
Results: Chloroma
Bakst R et al Int J Radiat Oncol Biol Phys 2012
• At a median follow-up of 11 months
since RT, local control was 97%
4 patients developed chloromas at other
sites
• Median dose was 20 (6-36) Gy
• RT was well tolerated without
significant acute or late effects, and
provided symptom relief in 95% of
cases
Site
% of Patients
Head & Neck 39
Extremity
24
Spine
9
Brain
9
GU
6
Breast
6
Pelvis
3
GI
3
RT Subsites